Comparison 3. Topical NSAID vs active comparator.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Clinical success	15		Risk Ratio (M-H, Fixed, 95% CI)	Totals not selected
1.1 Topical vs oral	3		Risk Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
1.2 Different formulations	4		Risk Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
1.3 Topical vs other topical	8		Risk Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 Clinical success- topical piroxicam v topical indomethacin	3	641	Risk Ratio (M-H, Fixed, 95% CI)	1.24 [1.07, 1.44]
3 Local adverse events - topical piroxicam vs topical indomethacin	3	671	Risk Ratio (M-H, Fixed, 95% CI)	0.21 [0.09, 0.47]